Knee Cartilage Repairing Market: By Treatment Modality, By Non-cell Based Approaches ), By Application, By Procedure Type, By End-User, Region Forecast 2020-2031
Knee Cartilage Repairing Market size was valued at US$ 4.4 billion in 2024 and is expected to reach US$ 7.5 billion by 2031, growing at a significant CAGR of 7.8% from 2025-2031. Cartilage is the rubbery and soft material present in bone joints and prevents friction between the bones. The market available in the market includes fibrocartilage, articular cartilage, and elastic cartilage. Knee cartilage damage mainly occurs due to osteoarticular disease, various physiological conditions, and accidents. Damage to the cartilage restricts normal movements of the knee causing pain and often occurs after traumatic and twisting injuries of the knee. Cartilage repair is beneficial for conditions like delayed unions, slow healing wounds, and malunions.
The knee cartilage repair market is growing at a significant CAGR due to the increase in the geriatric population. The increase in the obese population, rising incidence of sports injuries, osteoarthritis, and chondrodystrophic leading are the major factors driving the growth of the market over the forecast period. Technological advancements, the rise in number of accidents & related injuries, and increasing demand for minimally invasive surgical products are the key factors boosting the growth of the market. However, the high cost of therapy and unfavorable reimbursement scenario are the major restraining factors of the market. Complexities of cartilage repair surgeries are also expected to hamper the growth of the knee repairing market over the forecast period.
Study Period
2025-2031Base Year
2024CAGR
7.8%Largest Market
North-AmericaFastest Growing Market
North-America
Rising incidence and prevalence of obesity and diabetes is expected to propel the knee cartilage repairing market over the forecast period. According to the American Heart Association (AHA), the global geriatric population may be increased to 20% of the total population by 2030 which is expected to boost the cartilage repair market over the forecast period. Increase in the road accidents (according to World Health Organization, approximately 1.25 million people die each year in road accidents worldwide), and sports-related injuries (according to American Orthopaedic Society for Sports Medicine, more than 3.5 Mn athletes has received treatment due to sports injuries every year) are expected to fuel the market over the forecast period. Developing technology in the knee cartilage repairing treatment also fuel the growth of the market. For instance, the German firm Amedrix GmbH has developed the minimally invasive surgical procedure for the treatment of cartilage defects.
North America accounts for a major revenue share in the global market followed by Europe. The factors which are responsible for the growth of Knee Cartilage Repairing Market in the region are an increase in geriatric population and rapid degenerative changes of the knees. Furthermore, the growth of the the market is partly driven by the expanded access to health insurance coverage in the U.S. through the Medicare and the Medicaid. Rise in prevalence of osteoporosis in France, U.K. (according to National Health Service, over 3 Mn people are affected to osteoporosis in the UK each year), and Germany is anticipated to bolster the market in the Europe region. The presence of skilled healthcare professionals as well as rising bone and joint disorders expected to create the huge demand for surgery products in Germany.
Asia Pacific is the most profitable region for market owing to increase in the prevalence of diabetes (according to International Diabetes Federation 2015, approximately 109.6 Mn people were affected with diabetes in China, 1 Mn cases were reported Australia, and 7.2 Mn diabetes cases in Japan), rise in prevalence of osteoporosis in Australia and New Zealand (according to the Osteoporosis Australia over 1 Mn Australians and as per Burden of Osteoporosis in New Zealand (BONZ), the number osteoporosis at different sites in the skeleton was 84,000 cases in 2007, which is expected to reach 116,000 by 2020), increase in demand for elder care and treatment for age related conditions, and rise in medical tourism in Asia Pacific region anticipated to fuel the market over the forecast period. Latin America and Middle East & Africa region are expected to fuel the demand for cartilage repair products during the forecast period due to increase in obese (overweight) population.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 4.4 billion |
|
Market Size in 2031 |
US$ 7.5 billion |
|
Market CAGR |
7.8% |
|
By Treatment Modality |
|
|
By Application |
|
|
By Procedure Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The knee cartilage repairing market size was valued at US$ 4.4 billion in 2024 and is expected to reach US$ 7.5 billion by 2031, growing at a significant CAGR of 7.8% from 2025-2031
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The market key players are Medtronic (U.S.), Zimmer Biomet Inc.) (U.S.), ConMed Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services, Inc.) (U.S.), Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), LifeNet Health, Inc. (U.S.), Anika Therapeutics, Inc. (U.S.), Stryker Corporation (U.S.), Vericel Corporation (U.S.)
| 1. Executive Summary |
| 2. Global Knee Cartilage Repairing Market Introduction |
| 2.1.Global Knee Cartilage Repairing Market - Taxonomy |
| 2.2.Global Knee Cartilage Repairing Market - Definitions |
| 2.2.1.Treatment Modality |
| 2.2.2.Application |
| 2.2.3.Procedure Type |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Global Knee Cartilage Repairing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Knee Cartilage Repairing Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Knee Cartilage Repairing Market By Treatment Modality, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Cell Based Approaches |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Non-Cell Based Approaches |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Knee Cartilage Repairing Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Hyaline Cartilage |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Fibrocartilage |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Knee Cartilage Repairing Market By Procedure Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Arthroscopic Chondroplasty |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Osteochondral Grafts Transplantation |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Autologous Chondrocyte |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Implants Transplant |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Cell-based Cartilage Resurfacing |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Microfracture |
| 7.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8. Global Knee Cartilage Repairing Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Orthopaedic Clinics |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Ambulatory Surgical Centres |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Knee Cartilage Repairing Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Knee Cartilage Repairing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Treatment Modality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cell Based Approaches |
| 10.1.2.Non-Cell Based Approaches |
| 10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hyaline Cartilage |
| 10.2.2.Fibrocartilage |
| 10.3. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Arthroscopic Chondroplasty |
| 10.3.2.Osteochondral Grafts Transplantation |
| 10.3.3.Autologous Chondrocyte |
| 10.3.4.Implants Transplant |
| 10.3.5.Cell-based Cartilage Resurfacing |
| 10.3.6.Microfracture |
| 10.3.7.Others |
| 10.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Orthopaedic Clinics |
| 10.4.3.Ambulatory Surgical Centres |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Knee Cartilage Repairing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Treatment Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cell Based Approaches |
| 11.1.2.Non-Cell Based Approaches |
| 11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hyaline Cartilage |
| 11.2.2.Fibrocartilage |
| 11.3. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Arthroscopic Chondroplasty |
| 11.3.2.Osteochondral Grafts Transplantation |
| 11.3.3.Autologous Chondrocyte |
| 11.3.4.Implants Transplant |
| 11.3.5.Cell-based Cartilage Resurfacing |
| 11.3.6.Microfracture |
| 11.3.7.Others |
| 11.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Orthopaedic Clinics |
| 11.4.3.Ambulatory Surgical Centres |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Knee Cartilage Repairing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Treatment Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cell Based Approaches |
| 12.1.2.Non-Cell Based Approaches |
| 12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hyaline Cartilage |
| 12.2.2.Fibrocartilage |
| 12.3. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Arthroscopic Chondroplasty |
| 12.3.2.Osteochondral Grafts Transplantation |
| 12.3.3.Autologous Chondrocyte |
| 12.3.4.Implants Transplant |
| 12.3.5.Cell-based Cartilage Resurfacing |
| 12.3.6.Microfracture |
| 12.3.7.Others |
| 12.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Orthopaedic Clinics |
| 12.4.3.Ambulatory Surgical Centres |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Knee Cartilage Repairing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Treatment Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cell Based Approaches |
| 13.1.2.Non-Cell Based Approaches |
| 13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Hyaline Cartilage |
| 13.2.2.Fibrocartilage |
| 13.3. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Arthroscopic Chondroplasty |
| 13.3.2.Osteochondral Grafts Transplantation |
| 13.3.3.Autologous Chondrocyte |
| 13.3.4.Implants Transplant |
| 13.3.5.Cell-based Cartilage Resurfacing |
| 13.3.6.Microfracture |
| 13.3.7.Others |
| 13.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Orthopaedic Clinics |
| 13.4.3.Ambulatory Surgical Centres |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Knee Cartilage Repairing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Treatment Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Cell Based Approaches |
| 14.1.2.Non-Cell Based Approaches |
| 14.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Hyaline Cartilage |
| 14.2.2.Fibrocartilage |
| 14.3. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Arthroscopic Chondroplasty |
| 14.3.2.Osteochondral Grafts Transplantation |
| 14.3.3.Autologous Chondrocyte |
| 14.3.4.Implants Transplant |
| 14.3.5.Cell-based Cartilage Resurfacing |
| 14.3.6.Microfracture |
| 14.3.7.Others |
| 14.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Orthopaedic Clinics |
| 14.4.3.Ambulatory Surgical Centres |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Medtronic (U.S) |
| 15.2.2.Zimmer Biomet Inc.) (U.S) |
| 15.2.3.ConMed Corporation (U.S) |
| 15.2.4.Depuy Synthes (Johnson and Johnson Services, Inc) (U.S) |
| 15.2.5.Arthrex, Inc. (U.S) |
| 15.2.6.Smith & Nephew PLC (U.K) |
| 15.2.7.LifeNet Health, Inc. (U.S) |
| 15.2.8.Anika Therapeutics, Inc. (U.S) |
| 15.2.9.Stryker Corporation (U.S) |
| 15.2.10.Vericel Corporation (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
